VEGF administration in chronic myocardial ischemia in pigs

Cardiovascular Research

Volumn 40, Issue 2, 1998, Pages 272-281

  Lopez, John J ^a   Laham, Roger J ^a   Stamler, Alon ^a   Pearlman, Justin D ^a   Bunting, Stuart ^c   Kaplan, Aaron ^b   Carrozza, Joseph P ^a   Sellke, Frank W ^a   Simons, Michael ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LocalMed Inc   (United States)

^c GENENTECH INC   (United States)

Author keywords

Angiogenesis; Growth factors; Magnetic Resonance Imaging; Myocardial ischemia; VEGF

Indexed keywords

RECOMBINANT VASCULOTROPIN;

ANGIOCARDIOGRAPHY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY DILATATION; DRUG EFFICACY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; INTRAARTERIAL DRUG ADMINISTRATION; INTRACORONARY INFUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SWINE;

ANIMALS; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ENDOTHELIAL GROWTH FACTORS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRA-ARTERIAL; LYMPHOKINES; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; RANDOM ALLOCATION; STATISTICS, NONPARAMETRIC; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0032211550     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00136-9     Document Type: Article

References (32)

1. [1] Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-10934.
2. [2] Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nature Med 1997;3:158-164.
3. [3] Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257(5075):1401-1403.
4. [4] Harada K, Grossman W, Friedman M, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994;94(2):623-630.
5. [5] Harada K, Friedman M, Lopez JJ, et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 1996;270(5 Pt 2):H1791-H802.
6. [6] Unger EF, Banai S, Shou M, et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994;266(4 Pt 2):H1588-H1595.
7. [7] Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89(5):2183-2189.
8. [8] Lazarous DF, Shou M, Scheinowitz M, et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996;94:1074-1082.
9. [9] Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 1993;265(2 Pt 2):H586-H592.
10. [10] Hariawala MD, Horowitz JJ, Esakof D, et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 1996;63(1):77-82.
11. [11] Yang R, Thomas G, Bunting S, et al. Effects of vascular endothelial growth factor on hemodynamic and cardiac performance. J Cardiovasc Pharmacol 1996;27:838-844.
12. [12] Longhurst J, Ordway G, Buja L. Evaluation of coronary native and coronary collateral pressure gradients in the conscious dog. Am J Cardiovasc Pathol 1987;1:79-90.
13. [13] Roth D, Maruoka Y, Rogers J, White F, Longhurst J, Bloor C. Development of coronary collateral circulation in left circumflex Ameroid-occluded swine myocardium. Am J Physiol 1987;253(5 Pt 2):H1279-1288.
14. [14] Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1995;1(10):1085-1089.
15. [15] Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5(3):587-592.
16. [16] Fujita M, Sasayama S, Asanoi H, Nakajima H, Sakai O, Ohno A. Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina. Circulation 1988;77(5):1022-1029.
17. [17] Carroll SM, White FC, Roth DM, Bloor CM. Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion. Circulation 1993;88:198-207.
18. [18] Kowallik P, Schulz R, Guth BD, et al. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 1991;83(3):974-982.
19. [19] VanRugge FP, Botreel JJ, Van der Walls EE, et al. Cardiac first pass myocardial perfusion in normal subjects assessed by sub-second Gd-DPTA enhanced MR imaging. J Comp Assisted Tomogr 1991;15:959-965.
20. [20] Pearlman J, Hogan R, Wiske P, Franklin T, Weyman A. Echocardiographic definition of the left ventricle centroid; analysis of methods for centroid calculation from a single tomogram. J Am Coll Cardiol 1990;16(4):986-992.
21. [21] Lopez J, Laham RJ, Carrozza JC, et al. Hemodynamic effects of intracoronary VEGF delivery: evidence of tachyphylaxis and NO dependence of response. Am J Physiol 1997;273:H1317-H1323.
22. [22] Bauters C, Asahara T, Zheng LP, et al. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hind-limb. Am J Physiol 1994;267:H1263-H1271.
23. [23] Bauters, C., Asahara, T., Zheng, L.P. et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 1995; 21(2): 314-24; discussion 324-5.
24. [24] Banai S, Jaklitsch MT, Casscells W, et al. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ Res 1991;69(1):76-85.
25. [25] Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992;16(2):181-191.
26. [26] Lopez JJ, Edelman ER, Stamler A, et al. Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary flow parameters. J Pharmacol Exp Ther 1997;282:385-390.
27. [27] Takeshita S, Pu LQ, Stein LA, et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994;90:II228-II234.
28. [28] Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994;93(2):662-670.
29. [29] Isner J, Walsh K, Symes J, et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 1995;91:2687-2692.
30. [30] Sellke FW, Wang SY, Stamler A, et al. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol 1996;271:H713-H720.
31. [31] White F, Carroll S, Magnet A, Bloorm C. Coronary collateral development in swine after coronary artery occlusion. Circ Res 1992;71(6):1490-1500.
32. [32] Gottsauner-Wolf M, Jang Y, Penn MS, et al. Quantitative evaluation of local drug delivery using the InfusaSleeve catheter. Cathet Cardiovasc Diagn 1997;42(1):102-108.